| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2011 | 2017 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1999 | 2020 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
myosin heavy chain 7 | 0.516 | 0.692 | 4.2E-16 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
solute carrier family 22 member 2 | 0.572 | 0.769 | 2.0E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
secretory leukocyte peptidase inhibitor | 0.449 | 0.846 | 9.0E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
phospholipase A2 group VII | 0.537 | 0.769 | 5.3E-22 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2012 | ||||||||
|
caspase 1 | 0.413 | 0.885 | 3.5E-05 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ATP binding cassette subfamily B member 11 | 0.566 | 0.654 | 1.6E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
suppressor of cytokine signaling 3 | 0.434 | 0.808 | 0.75 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
solute carrier family 38 member 5 | 0.751 | 0.346 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
CD14 molecule | 0.392 | 0.885 | 4.9E-05 |
|
phenotype | 0.230 | None | 0.750 | 1 | 0 | 2002 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1989 | 2008 | ||||||||
|
vascular cell adhesion molecule 1 | 0.422 | 0.808 | 0.80 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2010 | 2020 | ||||||||
|
complement C5a receptor 1 | 0.513 | 0.808 | 0.40 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
secreted protein acidic and cysteine rich | 0.445 | 0.846 | 0.89 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2007 | 2009 | ||||||||
|
thromboxane A synthase 1 | 0.619 | 0.615 | 1.4E-20 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
actin alpha cardiac muscle 1 | 0.610 | 0.538 | 0.74 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
thrombomodulin | 0.457 | 0.769 | 5.4E-02 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2003 | 2018 |